pubmed-article:3197744 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C0439792 | lld:lifeskim |
pubmed-article:3197744 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
pubmed-article:3197744 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3197744 | pubmed:dateCreated | 1989-1-26 | lld:pubmed |
pubmed-article:3197744 | pubmed:abstractText | Chronic coadministration of oral verapamil with oral atenolol resulted in a variable increase in atenolol steady-state plasma concentrations in a group of 10 patients on chronic maintenance therapy. Individual subjects showed changes in area under the plasma atenolol concentration-time curve (AUC) of more than 100%, however group comparisons did not achieve statistical significance unless normalized for verapamil dose. Renal clearance of atenolol was shown to be decreased by more than 25% in 2 subjects studied using intravenous dosing of atenolol. This interaction is likely to contribute to the documented clinical intolerance of combinations of atenolol and verapamil. | lld:pubmed |
pubmed-article:3197744 | pubmed:language | eng | lld:pubmed |
pubmed-article:3197744 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3197744 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3197744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3197744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3197744 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3197744 | pubmed:issn | 0031-6970 | lld:pubmed |
pubmed-article:3197744 | pubmed:author | pubmed-author:HarrisonP MPM | lld:pubmed |
pubmed-article:3197744 | pubmed:author | pubmed-author:McLeanA JAJ | lld:pubmed |
pubmed-article:3197744 | pubmed:author | pubmed-author:HarperR WRW | lld:pubmed |
pubmed-article:3197744 | pubmed:author | pubmed-author:PittAA | lld:pubmed |
pubmed-article:3197744 | pubmed:author | pubmed-author:KeechA CAC | lld:pubmed |
pubmed-article:3197744 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3197744 | pubmed:volume | 35 | lld:pubmed |
pubmed-article:3197744 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3197744 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3197744 | pubmed:pagination | 363-6 | lld:pubmed |
pubmed-article:3197744 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:meshHeading | pubmed-meshheading:3197744-... | lld:pubmed |
pubmed-article:3197744 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3197744 | pubmed:articleTitle | Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man. | lld:pubmed |
pubmed-article:3197744 | pubmed:affiliation | Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Victoria, Australia. | lld:pubmed |
pubmed-article:3197744 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3197744 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:3197744 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |